Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma

Por Tanos, Rachel, Karmali, Dipan, Nalluri, Srilatha, Goldsmith, Kelly C.
Publicado no BMC Cancer (2016)

Role of the Ah Receptor in Homeostatic Control of Fatty Acid Synthesis in the Liver

Por Tanos, Rachel, Murray, Iain A., Smith, Philip B., Patterson, Andrew, Perdew, Gary H.
Publicado em 2012

Ah receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner

Por Tanos, Rachel, Patel, Rushang D., Murray, Iain A., Smith, Philip B., Perdew, Gary H.
Publicado em 2012

EGFR signaling defines Mcl(-)1 survival dependency in neuroblastoma

Por Nalluri, Srilatha, Peirce, Susan K, Tanos, Rachel, Abdella, Haneen A, Karmali, Dipan, Hogarty, Michael D, Goldsmith, Kelly C
Publicado no Cancer Biol Ther (2015)

Identification of a High-Affinity Ligand That Exhibits Complete Aryl Hydrocarbon Receptor Antagonism

Por Smith, Kayla J., Murray, Iain A., Tanos, Rachel, Tellew, John, Boitano, Anthony E., Bisson, William H., Kolluri, Siva K., Cooke, Michael P., Perdew, Gary H.
Publicado em 2011

Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021

Por Wetmore, Cynthia, Daryani, Vinay M., Billups, Catherine A., Boyett, James M., Leary, Sarah, Tanos, Rachel, Goldsmith, Kelly C., Stewart, Clinton F., Blaney, Susan M., Gajjar, Amar
Publicado no Cancer Med (2016)

Suppression of Cytokine-Mediated Complement Factor Gene Expression through Selective Activation of the Ah Receptor with 3′,4′-Dimethoxy-α-naphthoflavone

Por Murray, Iain A., Flaveny, Colin A., Chiaro, Christopher R., Sharma, Arun K., Tanos, Rachel S., Schroeder, Jennifer C., Amin, Shantu G., Bisson, William H., Kolluri, Siva K., Perdew, Gary H.
Publicado em 2011